rs6852441 — SLC2A9

SLC2A9 rs6852441 — A Urate-Haplotype Tag Variant at the Strongest Genetic Locus for Uric Acid

Your kidneys filter roughly 70% of the uric acid your body excretes each day, and the SLC2A9 gene — encoding the GLUT9 transporter¹¹ GLUT9 transporter
Glucose Transporter 9, a voltage-sensitive high-capacity urate transporter expressed on the basolateral membrane of the renal proximal tubule — is the single most important genetic regulator of how efficiently that process happens. rs6852441 is an intronic variant that tags a regulatory haplotype within this gene, with a population frequency pattern that mirrors the established risk architecture of the SLC2A9 locus: high risk-allele frequency in East Asians (where gout prevalence is greatest), low risk-allele frequency in Africans (where urate-related disease has historically been lower).

The Mechanism

rs6852441 lies within an intron of SLC2A9 and does not alter the GLUT9 protein sequence. Its functional significance, like other established intronic SLC2A9 variants (rs11942223, rs6815001, rs6814664), is regulatory: it tags a haplotype block that influences the expression, splicing, or basolateral trafficking of GLUT9 in renal proximal tubule cells. GLUT9 operates as a high-capacity electrogenic urate transporter, exchanging intracellular urate for extracellular glucose or fructose across the basolateral membrane. Variants on the risk haplotype appear to reduce net urate clearance, shifting the steady-state serum urate upward.

The C allele at rs6852441 (the GRCh38 reference) is the risk haplotype tag, found at approximately 90% frequency in East Asian populations — where gout incidence is among the highest globally — and at only about 38% in African populations, where urate-related disease has been lower. This inverse population gradient is consistent with the direction of effect seen for other established SLC2A9 intronic risk haplotype markers at this locus (Wei et al., 2014)²² (Wei et al., 2014).

The Evidence

SLC2A9 as the major urate locus: Two landmark 2008 Nature Genetics studies simultaneously established SLC2A9 as the most significant genetic determinant of serum uric acid in Europeans, with intronic variants explaining 1.7–5.3% of serum urate variance overall and up to 6% in women (Vitart et al., 2008)³³ (Vitart et al., 2008); (Döring et al., 2008)⁴⁴ (Döring et al., 2008). Carriers of risk alleles at SLC2A9 intronic variants show consistently higher serum uric acid across European, American Indian, Mexican American, and East Asian populations (Voruganti et al., 2013)⁵⁵ (Voruganti et al., 2013).

Complex local architecture: Detailed mapping of the 4p16.1 region by Wei et al. (2014) found that a five-SNP model incorporating marginal effects and epistatic interactions explained an additional 1.5% of serum urate variance beyond the lead SNP alone (Wei et al., 2014)⁶⁶ (Wei et al., 2014). The epistatically interacting SNPs are enriched at active enhancer chromatin marks in hepatic and blood cell lines, supporting a transcriptional regulation mechanism — consistent with rs6852441's intronic location at this locus.

Gout association: SLC2A9 intronic risk-allele carriers show elevated gout risk across multiple ethnic populations. Hollis-Moffatt et al. (2009) confirmed that major-allele genotypes at multiple SLC2A9 intronic variants were associated with gout in Māori, Pacific Island, and Caucasian case-control samples (OR >2.0 in Māori and Pacific groups) (Hollis-Moffatt et al., 2009)⁷⁷ (Hollis-Moffatt et al., 2009).

Sex-specific effects: The intronic SLC2A9 signal has a substantially larger effect in women than in men across all cohorts studied, with variance explained reaching ~6% in women versus ~1.2% in men. This sex difference is attributed to estrogen's independent stimulation of renal urate excretion, which amplifies the genetic signal in women but partially offsets it during the reproductive years (Döring et al., 2008)⁸⁸ (Döring et al., 2008).

Practical Actions

Carriers of CC at rs6852441 carry two copies of the risk haplotype tag associated with reduced renal urate clearance from this SLC2A9 signal. The practical implications follow the well-established SLC2A9 urate-management evidence base: eliminate sugar-sweetened beverages (the highest-leverage dietary action for SLC2A9 risk genotypes), reduce dietary purines, and establish a serum uric acid baseline to know where you stand.

The most important gene-environment interaction for this SLC2A9 locus is fructose: sugar-sweetened beverages raise urate through direct hepatic production and also impair GLUT9-mediated renal clearance through competitive inhibition, compounding the genetic risk from the C allele. Eliminating SSBs can reduce serum urate by 0.5–1 mg/dL in susceptible individuals — an effect comparable in magnitude to the genetic contribution of the risk haplotype itself.

Post-menopausal women with CC genotype are particularly exposed because estrogen's uricosuric contribution — which buffers the genetic risk during reproductive years — is withdrawn at menopause, often unmasking clinically significant hyperuricemia for the first time.

Interactions

rs11942223 (SLC2A9 intronic, independent signal): rs11942223 tags a second, genetically independent signal at the SLC2A9 locus (r² = 0.03–0.05 with rs3733591) with its own additive contribution to serum urate. Carrying risk alleles at both rs6852441 and rs11942223 compounds the urate elevation from two independent SLC2A9 regulatory mechanisms.

rs3733591 (SLC2A9 Arg265His missense): The coding variant Arg265His affects GLUT9 transport efficiency directly through a protein-level mechanism independent of rs6852441's regulatory effect. Risk alleles at both compounds the overall SLC2A9-mediated urate retention burden.

rs2231142 (ABCG2 Q141K): ABCG2 reduces intestinal urate secretion through an entirely separate pathway. Carrying risk alleles at rs6852441 (renal reabsorption) and ABCG2 rs2231142 (intestinal secretion) is additive and can produce serum urate above 7 mg/dL even without major dietary provocation.

Fructose and sugar-sweetened beverages: A gene-environment interaction between SLC2A9 genotype and SSB consumption has been documented at this locus: the normally urate-lowering protective allele has its benefit reversed by regular SSB intake, making fructose avoidance important regardless of which allele a person carries, and especially critical for CC risk-allele homozygotes.